These features render it compatible with adoptive cell transfer in allogeneic settings by preventing GvHD and allowing it to evade the cytolytic activities of NK cells and alloresponsive CD8(+) T cells, the two major actors of HvG rejection. The gene discussed is CD8A; the disease is graft versus host disease.